Literature DB >> 17609640

The ischemic stroke patient who worsens: new assessment and management approaches.

Latisha K Ali1, Jeffrey L Saver.   

Abstract

The stroke patient who deteriorates presents a common and rewarding diagnostic challenge. Up to one third of ischemic stroke patients worsen after admission, though the frequency of deterioration is declining with modern supportive care. The causes of clinical worsening are diverse; common etiologies include collateral failure, brain edema, seizures, reocclusion after successful initial therapeutic recanalization, and systemic medical complications. Clot propagation and recurrent embolization are only infrequent mechanisms of worsening. The advent of multimodal computed tomography and magnetic resonance imaging has transformed the evaluation of the deteriorating stroke patient. History, physical examination, screening blood work, and emergent reassessment of the cervical and cerebral vasculatures, regional hypoperfusion, and infarct core will yield a firm diagnosis of the cause of clinical worsening in the majority of patients. The therapeutic armamentarium for the worsening stroke patient has expanded greatly. Treatment options now include rescue late endovascular recanalization therapy, pressor collateral enhancement therapy, hemicraniectomy, and additional novel interventions in addition to enhanced supportive care. Because most causes of worsening can be treated effectively, the deteriorating stroke patient merits a swift and incisive diagnostic and therapeutic response.

Entities:  

Mesh:

Year:  2007        PMID: 17609640

Source DB:  PubMed          Journal:  Rev Neurol Dis        ISSN: 1545-2913


  9 in total

1.  Intracranial pressure elevation reduces flow through collateral vessels and the penetrating arterioles they supply. A possible explanation for 'collateral failure' and infarct expansion after ischemic stroke.

Authors:  Daniel J Beard; Damian D McLeod; Caitlin L Logan; Lucy A Murtha; Mohammad S Imtiaz; Dirk F van Helden; Neil J Spratt
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

2.  Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke.

Authors:  Andria L Ford; Hongyu An; Gina D'Angelo; Rosana Ponisio; Patrick Bushard; Katie D Vo; William J Powers; Weili Lin; Jin-Moo Lee
Journal:  Stroke       Date:  2011-03-31       Impact factor: 7.914

3.  Early changes of tissue perfusion after tissue plasminogen activator in hyperacute ischemic stroke.

Authors:  Hongyu An; Andria L Ford; Katie Vo; Cihat Eldeniz; Rosana Ponisio; Hongtu Zhu; Yimei Li; Yasheng Chen; William J Powers; Jin-Moo Lee; Weili Lin
Journal:  Stroke       Date:  2010-12-09       Impact factor: 7.914

Review 4.  National Institutes of Health Stroke Scale as an Outcome in Stroke Research: Value of ANCOVA Over Analyzing Change From Baseline.

Authors:  Eva A Mistry; Sharon D Yeatts; Pooja Khatri; Akshitkumar M Mistry; Michelle Detry; Kert Viele; Frank E Harrell; Roger J Lewis
Journal:  Stroke       Date:  2022-01-11       Impact factor: 7.914

5.  Frequency, Predictors, and Outcomes of Prehospital and Early Postarrival Neurological Deterioration in Acute Stroke: Exploratory Analysis of the FAST-MAG Randomized Clinical Trial.

Authors:  Kristina Shkirkova; Jeffrey L Saver; Sidney Starkman; Gregory Wong; Julius Weng; Scott Hamilton; David S Liebeskind; Marc Eckstein; Samuel Stratton; Frank Pratt; Robin Conwit; Nerses Sanossian
Journal:  JAMA Neurol       Date:  2018-11-01       Impact factor: 18.302

Review 6.  Systemic delivery of umbilical cord blood cells for stroke therapy: a review.

Authors:  Guolong Yu; Cesar V Borlongan; Christine E Stahl; David C Hess; Yali Ou; Yuji Kaneko; Seong Jin Yu; Tianlun Yang; Li Fang; Xiumei Xie
Journal:  Restor Neurol Neurosci       Date:  2009       Impact factor: 2.406

7.  Reperfusion Beyond 6 Hours Reduces Infarct Probability in Moderately Ischemic Brain Tissue.

Authors:  Hongyu An; Andria L Ford; Cihat Eldeniz; Yasheng Chen; Katie D Vo; Hongtu Zhu; William J Powers; Weili Lin; Jin-Moo Lee
Journal:  Stroke       Date:  2015-11-19       Impact factor: 7.914

8.  Is clopidogrel better than aspirin following breakthrough strokes while on aspirin? A retrospective cohort study.

Authors:  Meng Lee; Yi-Ling Wu; Jeffrey L Saver; Hsuei-Chen Lee; Jiann-Der Lee; Ku-Chou Chang; Chih-Ying Wu; Tsong-Hai Lee; Hui-Hsuan Wang; Neal M Rao; Bruce Ovbiagele
Journal:  BMJ Open       Date:  2014-12-02       Impact factor: 2.692

9.  Multi-ancestry genetic study in 5,876 patients identifies an association between excitotoxic genes and early outcomes after acute ischemic stroke.

Authors:  Laura Ibanez; Laura Heitsch; Caty Carrera; Fabiana H G Farias; Rajat Dhar; John Budde; Kristy Bergmann; Joseph Bradley; Oscar Harari; Chia-Ling Phuah; Robin Lemmens; Alessandro A Viana Oliveira Souza; Francisco Moniche; Antonio Cabezas-Juan; Juan Francisco Arenillas; Jerzy Krupinksi; Natalia Cullell; Nuria Torres-Aguila; Elena Muiño; Jara Cárcel-Márquez; Joan Marti-Fabregas; Raquel Delgado-Mederos; Rebeca Marin-Bueno; Alejandro Hornick; Cristofol Vives-Bauza; Rosa Diaz Navarro; Silvia Tur; Carmen Jimenez; Victor Obach; Tomas Segura; Gemma Serrano-Heras; Jong-Won Chung; Jaume Roquer; Carol Soriano-Tarraga; Eva Giralt-Steinhauer; Marina Mola-Caminal; Joanna Pera; Katarzyna Lapicka-Bodzioch; Justyna Derbisz; Antoni Davalos; Elena Lopez-Cancio; Lucia Muñoz; Turgut Tatlisumak; Carlos Molina; Marc Ribo; Alejandro Bustamante; Tomas Sobrino; Jose Castillo-Sanchez; Francisco Campos; Emilio Rodriguez-Castro; Susana Arias-Rivas; Manuel Rodríguez-Yáñez; Christina Herbosa; Andria L Ford; Antonio Arauz; Iscia Lopes-Cendes; Theodore Lowenkopf; Miguel A Barboza; Hajar Amini; Boryana Stamova; Bradley P Ander; Frank R Sharp; Gyeong Moon Kim; Oh Young Bang; Jordi Jimenez-Conde; Agnieszka Slowik; Daniel Stribian; Ellen A Tsai; Linda C Burkly; Joan Montaner; Israel Fernandez-Cadenas; Jin-Moo Lee; Carlos Cruchaga
Journal:  medRxiv       Date:  2020-11-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.